Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

Memorial Sloan Kettering Nassau, New York

Fox Chase Cancer Center, Philadelphia

Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore

Blumenthal Cancer Center, Charlotte

Tennessee Oncology, PLLC, Nashville

Cleveland Clinic, Cleveland

City Of Hope, Duarte

Beth Israel Deaconess Medical Center, Boston

Dartmouth-Hitchcock Medical Center, Lebanon

University Of Texas M.D. Anderson Cancer Center, Houston

Tom Baker Cancer Centre, Calgary

Cross Cancer Institute, Edmonton

BC Cancer Agency - Vancouver Centre, Vancouver

Princess Margaret Cancer Centre, Toronto